USADA grants Gian Villante retroactive exemption after positive test

USADA grants Gian Villante retroactive exemption after positive test

Gian Villante failed a USADA test last month, turns out, he’s ok.

UFC light heavyweight Gian Villante nearly found himself in hot water, after failing a USADA test in January for a banned substance in his inhaler.  The inhaler is used for people with asthma and other breathing ailments. Villante told the USADA tester that he was using the product while being tested out of competition test on January 18th.

USADA issued Villante a TUE (Therapeutic Use Exemption) for the medication and he will not face any punishment for the failed test. The product in question is the Breo Ellipta.  The inhaler contains the banned substance vilanterol.  Vilanterol is prohibited at all times and is listed as a Beta-2 Agonist. USADA investigated and found that the medication was a necessary medical treatment for Villante, and issued the TUE in response.

USADA recently granted Cristiane “Cyborg” a TUE for the loop diuretic Spironolactone, after a hearing. Initially, Cyborg was flagged and suspended for the use of the banned substance. She has since been granted the exemption and is now cleared to return to action.

Get to know Gian Villante:

Twitter
Instagram
UFC Profile